Incidence and survival patterns of cutaneous T-cell lymphomas in the United States

References

• Lessin SR. Alibert lymphoma: renaming mycosis fungoides. Arch Dermatol 2009;145:209–210.
   PubMed Web of Science ®Google Scholar
• Jaffe ES, Harris NL, Diebold J, . World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am J Clin Pathol 1999;111:S8–S12.
   PubMed Web of Science ®Google Scholar
• Willemze R, Kerl H, Sterry W, . EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354–371.
   PubMed Web of Science ®Google Scholar
• Willemze R, Jaffe ES, Burg G, . WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–3785.
   PubMed Web of Science ®Google Scholar
• Bradford PT, Devesa SS, Anderson WF, . Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 2009;113:5064–5073.
   PubMed Web of Science ®Google Scholar
• Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol 2007;143: 854–859.
   PubMed Web of Science ®Google Scholar
• Assaf C, Gellrich S, Steinhoff M, . Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG). J Dtsch Dermatol Ges 2007;5:662–668.
   PubMedGoogle Scholar
• Morton LM, Turner JJ, Cerhan JR, . Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;110:695–708.
   PubMed Web of Science ®Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 9 Regs Limited-Use, Nov 2009 Sub (1973-2007) <Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969-2007 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission. Available from: www.seer.cancer.gov/
   Google Scholar
• Ries LAG, Kosary CL, Hankey BF, ., editors. SEER Cancer Statistics Review, 1973–1994. NIH Pub. No. 97-2789. Bethesda, MD: National Cancer Institute; 1997.
   Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 13 Regs Limited-Use, Nov 2009 Sub (1992–2007) <Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969–2007 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission. Available from: www.seer.cancer.gov/
   Google Scholar
• Hankey BF, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results program: a national resource. Cancer Epidemiol Biomarkers Prev 1999;8:1117–1121.
   PubMed Web of Science ®Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 17 Regs Limited-Use + Hurricane Katrina impacted Louisiana Cases, Nov 2009 Sub (2000–2007) <Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969–2007 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission. Available from: www.seer.cancer.gov/
   Google Scholar
• Fritz A, Percy C, Jack A, ., editors. International classification of diseases for oncology, 3rd ed. Geneva: World Health Organization; 2000.
   Google Scholar
• NAACCR Race and Ethnicity Work Group. NAACCR Asian Pacific Islander Identification Algorithm [NAPIIA v1.2.1]. Springfield, IL: North American Association of Central Cancer Registries; 2010.
   Google Scholar
• Ries LAG, Eisner MP, Kosary CL, . SEER Cancer Statistics Review, 1975–2001. Bethesda, MD: National Cancer Institute; 2004.
   Google Scholar
• U.S. Census Bureau. National population projections I. Summary files [Internet]. December 11, 2006. Available from: http://www.census.gov/population/www/projections/natsum-T3.html
   Google Scholar
• Brown CC. The statistical comparison of relative survival rates. Biometrics 1983;39:941–948.
   PubMed Web of Science ®Google Scholar
• Morton LM, Wang SS, Devesa SS, . Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 2006; 107:265–276.
   PubMed Web of Science ®Google Scholar
• Shenoy PJ, Malik N, Sinha R, . Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States. Clin Lymphoma Myeloma Leuk 2011; 11:498–506.
   PubMed Web of Science ®Google Scholar
• Wang M, Burau KD, Fang S, . Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma. Cancer 2008;113:3231–3241.
   PubMed Web of Science ®Google Scholar
• Flowers CR, Glover R, Lonial S, . Racial differences in the incidence and outcomes for patients with hematological malignancies. Curr Prob Cancer 2007;31:182–201.
   PubMedGoogle Scholar
• Abouyabis AN, Shenoy PJ, Lechowicz MJ, . Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma 2008;49:2099–2107.
   PubMed Web of Science ®Google Scholar
• Shenoy PJ, Malik N, Nooka A, . Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer 2010 Dec 22. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Flowers CR, Shenoy PJ, Borate U, . Examining racial differences in diffuse large B-cell lymphoma presentation and survival. Leuk Lymphoma 2012 Jul 16. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Nabhan C, Byrtek M, Taylor MD, . Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study. Cancer 2012;118:4842–4850.
   PubMed Web of Science ®Google Scholar
• Weinstock MA, Reynes JF. The changing survival of patients with mycosis fungoides. Cancer 1999;85:208–212.
   PubMed Web of Science ®Google Scholar
• Lehman JS, Cook-Norris RH, Weed BR, . Folliculotropic mycosis fungoides: single-center study and systematic review. Arch Dermatol 2010;146:607–613.
   PubMed Web of Science ®Google Scholar
• Kempf W, Ostheeren-Michaelis S, Paulli M, . Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). Arch Dermatol 2008;144:1609–1617.
   PubMed Web of Science ®Google Scholar
• Markova A, Weinstock MA. Trends in cutaneous lymphoma epidemiology. Clin Lymphoma Myeloma Leuk 2010;10:S63–S66.
   Web of Science ®Google Scholar
• Yu JB, Blitzblau RC, Decker RH, . Analysis of primary CD30+ cutaneous lymphoproliferative disease and survival from the Surveillance, Epidemiology, and End Results database. J Clin Oncol 2008;26:1483–1488.
   PubMed Web of Science ®Google Scholar
• Ghosh SK, Abrams JT, Terunuma H, . Human T-cell leukemia virus type I tax/rex DNA and RNA in cutaneous T-cell lymphoma. Blood 1994;84:2663–2671.
   PubMed Web of Science ®Google Scholar
• Wood GS, Salvekar A, Schaffer J, . Evidence against a role for human T-cell lymphotrophic virus type I (HTLV-I) in the pathogenesis of American cutaneous T-cell lymphoma. J Investig Dermatol 1996; 107:301–307.
   PubMed Web of Science ®Google Scholar
• Weinstock MA, Gardstein B. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health 1999;89:1240–1244.
   PubMed Web of Science ®Google Scholar
• Weinstock MA, Horm JW. Population-based estimate of survival and determinants of prognosis in patients with mycosis fungoides. Cancer 1988;62:1658–1661.
   PubMed Web of Science ®Google Scholar
• Wilcox RA. Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 2011;86: 928–948.
   PubMed Web of Science ®Google Scholar
• Bunn PA Jr, Lamberg SI. Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Cancer Treat Rep 1979;63:725–728.
   PubMedGoogle Scholar
• Olsen E, Vonderheid E, Pimpinelli N, . Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007;110: 1713–1722.
   PubMed Web of Science ®Google Scholar
• Hinds GA, Heald P. Cutaneous T-cell lymphoma in skin of color. J Am Acad Dermatol 2009;60:359–375; quiz 376–378.
   PubMed Web of Science ®Google Scholar
• AbouYabis AN, Shenoy PJ, Sinha R, . A systematic review and meta-analysis of frontline anthracycline-based chemotherapy regimens for peripheral T-cell lymphoma. ISRN Hematology 2011; 2011:623924.
   PubMedGoogle Scholar
• Matasar MJ, Ritchie EK, Consedine N, . Incidence rates of the major leukemia subtypes among U.S. Hispanics, Blacks, and non-Hispanic Whites. Leuk Lymphoma 2006;47:2365–2370.
   PubMed Web of Science ®Google Scholar
• Yamamoto J, Goodman M. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002. Cancer Causes Control 2008;19:379–390.
   PubMed Web of Science ®Google Scholar
• Halder RM, Bang KM. Skin cancer in blacks in the United States. Dermatol Clin 1988;6:397–405.
   PubMed Web of Science ®Google Scholar
• Kim YH, Liu HL, Mraz-Gernhard S, . Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol 2003;139:857–866.
   PubMed Web of Science ®Google Scholar
• Mordukhovich I, Reiter PL, Backes DM, . A review of African American-white differences in risk factors for cancer: prostate cancer. Cancer Causes Control 2011;22:341–357.
   PubMed Web of Science ®Google Scholar
• Clarke CA, Undurraga DM, Harasty PJ, . Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol Biomarkers Prev 2006;15:630–638.
   PubMed Web of Science ®Google Scholar
• Dores GM, Curtis RE, Anderson WF, . Assessment of delayed reporting of mycosis fungoides and Sezary syndrome in the United States. Arch Dermatol 2008;144:413–414.
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10–29.
   PubMed Web of Science ®Google Scholar